The US market for advanced visualization systems is a largely mature market that will decline slightly over the forecast period as a result of hospital consolidation, and a move away from capital-expenditure-intensive thick-client workstations. However, the market will be supported by the growth of imaging-intensive procedures in cardiology and oncology departments.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for advanced visualization systems in the US across a 10-year period.
Questions Answered in This Report:
The US advanced visualization system market has been transitioning away from thick-client workstations and toward thin- or zero-client solutions.
- What impact is this having on unit sales and ASPs in this market?
- How will competitors attract clients as the industry shifts to thin- or zero-client solutions?
While the overall US market will grow slowly, there are particular opportunities for growth in the radiology, cardiology, and oncology spaces.
- What factors are driving the adoption of advanced visualization applications in radiology, cardiology, and oncology departments?
- Is the growth in imaging-intensive procedures in these departments sustainable over the forecast period?
- Which companies are the leaders in this space? What strategies are they using to remain competitive?
- Which procedures will drive the adoption of advanced visualization applications over the forecast period?
- What diagnostic and non-diagnostic needs are companies looking to cater to?
Many PACS vendors are pulling advanced visualization capability into enterprise-wide PACS solutions.
- How are competitors in this space, particularly independent application vendors and imaging modality vendors, reacting to this development?
- What advantages does a facility have if it decides to integrate its advanced visualization software directly into its PACS?